SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is currently trending amidst heightened retail interest and a surging community dialogue about its potential for a significant breakout. Despite some historical underperformance, traders are keenly observing technical indicators and anticipating a major rally, with many viewing current price levels as a critical opportunity before an expected upward move.

ESH Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 17, 2021 and is headquartered in New York, NY.

ESH Acquisition Corp - Ordinary Shares - Class A

ESHA is generating significant buzz, primarily driven by its extremely low public float and high insider ownership, fueling speculation among traders about a potential short squeeze. The community is actively comparing its recent volatility and rapid price movements to other trending SPACs, with discussions often focusing on its merger agreement and aggressive upside potential.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions is trending following a recent manufacturing partnership announcement, which has intensified short-squeeze activity driven by its extremely low public float after a recent reverse stock split. The community is actively discussing the stock's significant volatility and potential for further upward momentum, contrasting with some calls for caution. This market dynamic unfolds as the company expands global adoption of its non-invasive fingerprint drug screening technology and navigates the FDA clearance process for the U.S. market.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending with high enthusiasm following its FDA approval for NEREUS, marking the first new motion sickness treatment in over four decades. The community is actively discussing the drug's game-changing potential, particularly its ability to address GLP-1 induced nausea, which presents a vast market opportunity and fuels speculation of a major pharma buyout. This significant regulatory win, alongside VNDA's robust pipeline and strong financial position, is driving widespread bullish sentiment.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics is trending after the FDA issued a Complete Response Letter for its relacorilant hypertension indication, triggering a sharp stock decline and intense community debate. Investors are divided, with many viewing the sell-off as an overreaction given the company's existing profitable drug and other pipeline programs, while others express caution regarding potential delays and future prospects.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is generating significant buzz following substantial insider share purchases by Apple CEO and Nike board member Tim Cook and its own CEO, Elliott Hill, signaling strong executive confidence. This activity has sparked a lively debate among investors, with many viewing it as a compelling turnaround story and value opportunity after recent market pressure, while some remain cautious about ongoing challenges and competitive headwinds.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings is trending after announcing significant new orders for its autonomous systems, bolstering its position in critical defense and infrastructure sectors. The community is expressing strong optimism, amplified by this robust demand and the recent launch of a 2X leveraged ETF, which has increased market visibility. Investors are actively discussing Ondas's expanding leadership in the multi-domain autonomy space, driven by global security needs and strategic growth.

Alchemy Investments Acquisition Corp. 1 is a blank check company, which engages in merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination. The company was founded on October 27, 2021 and is headquartered in Newark, DE.

Alchemy Investments Acquisition Corp 1 - Ordinary Shares - Class A

ALCY is capturing significant attention amid a broader "low float SPAC" trend, drawing parallels to recent high-volume movements in similar vehicles. Community sentiment is highly optimistic, anticipating a breakout fueled by its limited share availability and a recent announcement regarding a potential merger with Cartiga, a litigation finance asset management platform. Traders are actively discussing rotational plays and expecting substantial momentum as part of this ongoing SPAC theme.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending due to the FDA granting Priority Review for its AXS-05 treatment for Alzheimer's disease agitation, with an action date anticipated in April, alongside positive updates for its narcolepsy candidate, AXS-12. This pivotal regulatory progress, coupled with strong sales growth for its existing Auvelity product, is driving significant community excitement, as investors anticipate continued pipeline advancements and a potential transition to a higher market valuation. Many believe the company is "killing it" and poised for substantial future gains, celebrating consistent product performance and strategic momentum in the CNS therapeutic space.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending amidst renewed optimism following China's confirmation of extended EV trade-in subsidies into 2026 and its CEO's upbeat Q4 outlook, which anticipates record deliveries and potential profitability. This positive context is met with fervent community debate, as many investors decry perceived market manipulation suppressing the stock despite improving fundamentals and expanding battery swap infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Crown Electrokinetics Corp. (CRKN) lost a third of their value in the after-market trading session on Tuesday after the company received a delisting notice from the Nasdaq.The company’s stock fell nearly 17% during the regular trading session.Crown also announced that its stock will be suspended from trading on Nasdaq when markets open on Wednesday. Instead, it will be eligible for trade on OTC Market’s “Pink Current Information” tier.The company said it intends to submit a request to Nasdaq to reconsider its delisting decision.This comes after the company’s shareholders <a href="https://stocktwits.com/news-articles/markets/equity/crown-electrokinetics-tumbles-after-shareholders-approve-reverse-stock-split/chGqNx0RVj">approved</a> a 1:200 reverse stock split in January as Crown underscored the importance of staying listed on the Nasdaq.“Crown has taken all the necessary steps to meet Nasdaq’s listing requirements, and we firmly believe the Company deserves to remain on the exchange,” said Doug Croxall, CEO and Chairman, Crown.Croxall has in the past <a href="https://stocktwits.com/news-articles/markets/equity/crown-electrokinetics-stock-declines-as-investors-get-ready-to-vote-on-reverse-stock-split-proposal/chGI3ugRmq">said</a> that the company’s market value does not reflect its potential.Crown’s stock will remain listed on the Nasdaq until a final decision is made, even though trading will be suspended beginning Wednesday.Retail users criticized recent decisions of the company, including the reverse stock split.<stembedurl>https://stocktwits.com/Bleachedsmiles/message/606785154</stembedurl><stembedurl>https://stocktwits.com/Ashland85/message/606779734</stembedurl>One user said they did not think Crown would “end up like this.”<stembedurl>https://stocktwits.com/WiganWarrior/message/606782357</stembedurl><a href="https://stocktwits.com/symbol/CRKN">Crown’s stock</a> has lost nearly 99% of its value in the past six months, and almost 87% since the beginning of 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See:<a href="https://stocktwits.com/news-articles/markets/equity/arbb-stock-more-than-doubles-aftermarket-on-45m-ai-data-center-order/cheZOCrRCs">&nbsp;ARBB Stock More Than Doubles Aftermarket On Bagging $45M AI Data Center Order: Retail Says 'Get In'</a>

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Crown Electrokinetics Tanks 33% Aftermarket On Nasdaq Delisting Notice: Retail Traders Fume Over Recent Moves

This comes after the company’s shareholders approved a 1:200 reverse stock split in January as Crown underscored the importance of staying listed on the Nasdaq.

Equity

Shares of Crown Electrokinetics Corp. (CRKN) lost&nbsp;more than a quarter of its market capitalization in Wednesday’s pre-market&nbsp;session after the company’s shareholders approved a 1:200 reverse stock split.Crown had called for a special meeting of shareholders on Jan. 14, and one of the key items on the agenda was to obtain authorization for a reverse stock split of up&nbsp;one share for every 200 shares issued.Shareholders also voted on the proposal for an independent registered public accounting firm. The company noted that all proposals were approved during the meeting.The reverse stock split authorization allows Crown Electrokinetics’ board to enact the split with a minimum ratio of 1:2, going all the way up to 1:200.“Maintaining our Nasdaq listing ensures access to the capital markets, which is needed to advance our mission in delivering innovative infrastructure solutions that benefit both communities and the environment,” said Doug Croxall, CEO of Crown Electrokinetics.Croxall had <a href="https://stocktwits.com/news-articles/markets/equity/crown-electrokinetics-stock-declines-as-investors-get-ready-to-vote-on-reverse-stock-split-proposal/chGI3ugRmq">earlier expressed anguish</a> over the company’s market value not reflecting its success potential.“We share in your frustration that our market value, trading at approximately our current cash value, does not yet reflect either Crown’s recent achievements or its immense future potential,” he said.Retail sentiment on Stocktwits was divided at the time of writing.<stembedurl>https://stocktwits.com/djgestates/message/600096004</stembedurl><stembedurl>https://stocktwits.com/Steel21/message/600086464</stembedurl><stembedurl>https://stocktwits.com/cgerdung/message/600088274</stembedurl>However, not everyone is sold on the bullish sentiment.<stembedurl>https://stocktwits.com/Chad_Thunderstock/message/600096410</stembedurl><stembedurl>https://stocktwits.com/Uncle_Charlie/message/600084789</stembedurl>In the past six months, <a href="https://stocktwits.com/symbol/CRKN">CRKN share price</a> has fallen by more than 97%, while its one-year performance has been worse, with a decline of over 99%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nokia-rises-pre-market-as-it-signs-multi-year-patent-deal-with-samsung/chGqm1ERVL">Nokia Rises Pre-Market On Signing Multi-Year Patent Deal With Samsung: Retail's Extremely Bullish</a>

Crown Electrokinetics Loses Over Quarter Of Its Market Cap After Shareholders Approve Reverse Stock Split: Retail’s Divided

Crown Electrokinetics’ board now has the discretion to enact a reverse stock split with a ratio of not less than 1:2, going all the way up to 1:200.

Shares of Crown Electrokinetics Corp. (CRKN) declined in morning trade on Tuesday, falling nearly 1% as investors&nbsp;got ready to vote on a reverse stock split proposal.In December, Crown CEO Doug Croxall had urged shareholders to vote in favor of a reverse stock split proposal. This, he said, was a “critical step” in making sure the company meets Nasdaq’s listing requirements.“As we scale, we are actively refining our business processes to align with our growing operations while maintaining agility and focus,” he said.Crown Electrokinetics guided for $30 million to $35 million in revenue for the 2025 financial year, which is an increase of 50% to 75% over 2024.That said, Croxall expressed anguish over the company’s valuation not reflecting its potential for success in the future.“We share in your frustration that our market value, trading at approximately our current cash value, does not yet reflect either Crown’s recent achievements or its immense future potential,” he said.Retail sentiment on Stocktwits was&nbsp;‘bullish’&nbsp;despite the CRKN stock’s volatile movement in Tuesday trade – in the pre-market hours and early trade, CRKN stock price gained over 4%. However, at the time of writing, it was down nearly 1%.Retail traders remained optimistic about CRKN’s prospects.<stembedurl>https://stocktwits.com/wilpj2025/message/599109827</stembedurl><stembedurl>https://stocktwits.com/PicassoGalileo/message/599109637</stembedurl><stembedurl>https://stocktwits.com/whatsgood75/message/599108978</stembedurl><stembedurl>https://stocktwits.com/CaptainsLogs/message/599108416</stembedurl>In the past six months, CRKN share price has fallen by more than 95%, while its one-year performance has been worse with a decline of over 99%.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/applied-digital-stock-rallies-as-company-appoints-new-coo/chGd2xzRmO">Applied Digital Stock Rallies As Company Appoints New COO: Retail Extremely Bullish</a>

Stock Trading Chart on Device Screen - stock photo

Crown Electrokinetics Stock Declines As Investors Get Ready To Vote On Reverse Stock Split Proposal Next Week: Retail Bullish

In December, Crown CEO Doug Croxall had urged shareholders to vote in favor of a reverse stock split proposal.

Crown ElectroKinetics Corp. engages in the commercialization of electro kinetic technology for use in the smart glass market. The firm operates through the following segments: Smart Windows division, Fiber Optics division, Slant Wells group, and Element 82. The Smart Windows division focuses on developing and selling optical switching films. The Fiber Optics division provides contracting services to the fiber optics and telecommunications infrastructure industry. The Slant Wells group focuses on the construction of slant wells for the provision of ocean water. The Element 82 is a water pipeline inspection service provider focused on lead detection and condition assessment. The company was founded by Douglas B. Croxall and Timothy Koch on April 20, 2015 and is headquartered in Corvallis, OR.

CRKN
Crown ElectroKinetics Corp

Feed

News

Sentiment

Fundamentals

Info

Latest CRKN News

CRKNCrown ElectroKinetics Corp